Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil

Journal of Chromatography A

Volumn 1129, Issue 2, 2006, Pages 153-159

  Fukutsu, Naoto ^a   Kawasaki, Takao ^a   Saito, Koichi ^b   Nakazawa, Hiroyuki ^b  

^a DAIICHI SANKYO CO   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Cefpodoxime proxetil; Degradation product; HPLC hyphenated technique; Stability

Indexed keywords

CEFPODOXIME PROXETIL; DEGRADATION PRODUCT; HPLC HYPHENATED TECHNIQUE;

ANTIBIOTICS; DEGRADATION; ESTERS; HYDROLYSIS; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PURIFICATION; SOLVENTS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CARBOXYL GROUP; CEFPODOXIME PROXETIL; CEPHALOSPORIN DERIVATIVE; ESTER; SOLVENT;

ANALYTIC METHOD; ARTICLE; DRUG DEGRADATION; DRUG FORMULATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; DRUG SOLUBILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SOLID STATE;

CEFTIZOXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; TEMPERATURE;

EID: 33748577336     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2006.06.102     Document Type: Article

References (13)

1. ICH Harmonised Tripartite Guideline Q1A(R2): Stability Testing of New Drug Substances and Products, International Conference on Harmonisation (ICH), 6 February 2003. (available at http://www.ich.org).
2. ICH Harmonised Tripartite Guideline Q3A(R): Impurities in New Drug Substances, International Conference on Harmonisation (ICH), 7 February 2002. (available at http://www.ich.org).
3. ICH Harmonised Tripartite Guideline Q3B(R): Impurities in New Drug Products, International Conference on Harmonisation (ICH), 5 February 2003. (available at http://www.ich.org).
4. Sharman G.J., and Jones I.C. Magn. Reson. Chem. 41 (2003) 448
5. Feng W., Liu H., Chen G., Malchow R., Bennett F., Lin E., Pramanik B., and Chan T. J. Pharm. Biomed. Anal. 25 (2001) 545
6. Peng S.X., Borah B., Dobson B.L.M., Liu Y.D., and Pikul S. J. Pharm. Biomed. Anal. 20 (1999) 75
7. Somensen G.W., Gooijer C., Brinkman U.A.Th., Velthorst N.H., and Visser T. Appl. Spectrosc. 46 (1992) 1514
8. DiNunzio J.E. J. Chromatogr. 626 (1992) 97
9. Stoeckel K., Hofheinz W., Laneury J.P., Duchene P., Shedlofsky S., and Blouin R.A. Antimicrob. Agents Chemother. 42 (1998) 2602
10. Miyauchi M., Sasahara K., Fujimoto K., Kawamoto I., Ide J., and Nakao H. Chem. Pharm. Bull. 37 (1989) 2369
11. Zaja{ogonek}c M., Jelińska A., Dobrowolski L., and Oszczapowicz I. J. Pharm. Biomed. Anal. 32 (2003) 1181
12. Jelińska A., Zaja{ogonek}c M., Gostomska J., and Szczepaniak M. IL Farmaco 58 (2003) 309
13. Olsen B.O., Perry F.M., Snorek S.V., and Lewellen P.L. Pharm. Dev. Technol. 2 (1997) 303